A phosphate and calcium-enriched diet promotes progression of 5/6-nephrectomy-induced chronic kidney disease in C57BL/6 mice.
Animals
Calcium
/ blood
Calcium, Dietary
/ adverse effects
Disease Progression
Fibroblast Growth Factor-23
Fibroblast Growth Factors
/ blood
Fibrosis
Glomerular Filtration Rate
Kidney
/ pathology
Mice, Inbred C57BL
Nephrectomy
/ adverse effects
Parathyroid Hormone
/ blood
Phosphates
/ blood
Phosphorus, Dietary
/ adverse effects
Renal Insufficiency, Chronic
/ blood
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
21 07 2021
21 07 2021
Historique:
received:
05
05
2021
accepted:
06
07
2021
entrez:
22
7
2021
pubmed:
23
7
2021
medline:
26
11
2021
Statut:
epublish
Résumé
C57BL/6 mice are known to be rather resistant to the induction of experimental chronic kidney disease (CKD) by 5/6-nephrectomy (5/6-Nx). Here, we sought to characterize the development of CKD and its cardiac and skeletal sequelae during the first three months after 5/6-Nx in C57BL/6 mice fed a calcium- and phosphate enriched diet (CPD) with a balanced calcium/phosphate ratio. 5/6-NX mice on CPD showed increased renal fibrosis and a more pronounced decrease in glomerular filtration rate when compared to 5/6-Nx mice on normal diet (ND). Interestingly, despite comparable levels of serum calcium, phosphate, and parathyroid hormone (PTH), circulating intact fibroblast growth factor-23 (FGF23) was 5 times higher in 5/6-Nx mice on CPD, relative to 5/6-Nx mice on ND. A time course experiment revealed that 5/6-Nx mice on CPD developed progressive renal functional decline, renal fibrosis, cortical bone loss, impaired bone mineralization as well as hypertension, but not left ventricular hypertrophy. Collectively, our data show that the resistance of C57BL/6 mice to 5/6-Nx can be partially overcome by feeding the CPD, and that the CPD induces a profound, PTH-independent increase in FGF23 in 5/6-Nx mice, making it an interesting tool to assess the pathophysiological significance of FGF23 in CKD.
Identifiants
pubmed: 34290280
doi: 10.1038/s41598-021-94264-8
pii: 10.1038/s41598-021-94264-8
pmc: PMC8295299
doi:
Substances chimiques
Calcium, Dietary
0
Fgf23 protein, mouse
0
Parathyroid Hormone
0
Phosphates
0
Phosphorus, Dietary
0
Fibroblast Growth Factors
62031-54-3
Fibroblast Growth Factor-23
7Q7P4S7RRE
Calcium
SY7Q814VUP
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
14868Informations de copyright
© 2021. The Author(s).
Références
PLoS One. 2016 Feb 25;11(2):e0150093
pubmed: 26914452
Semin Thromb Hemost. 2004 Oct;30(5):579-89
pubmed: 15497100
Kidney Int. 2019 Dec;96(6):1346-1358
pubmed: 31668632
Kidney Int. 2011 Jun;79(12):1370-8
pubmed: 21389978
Nat Med. 2010 May;16(5):535-43, 1p following 143
pubmed: 20436483
J Clin Invest. 2011 Nov;121(11):4393-408
pubmed: 21985788
Kidney Int. 2019 Oct;96(4):890-905
pubmed: 31301888
Am J Physiol Renal Physiol. 2019 Aug 1;317(2):F286-F295
pubmed: 31116604
Endocrinology. 2018 May 1;159(5):2165-2172
pubmed: 29635291
Adv Chronic Kidney Dis. 2011 Mar;18(2):113-9
pubmed: 21406296
Clin J Am Soc Nephrol. 2016 Jun 6;11(6):1088-100
pubmed: 26912542
N Engl J Med. 2004 Sep 23;351(13):1296-305
pubmed: 15385656
J Am Soc Nephrol. 2001 Dec;12(12):2721-2731
pubmed: 11729241
Int J Nephrol Renovasc Dis. 2019 Dec 24;12:263-276
pubmed: 31920363
J Bone Miner Res. 1991 Mar;6(3):273-8
pubmed: 2035354
Kidney Int. 1995 Jan;47(1):186-92
pubmed: 7731145
Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1049-58
pubmed: 24677555
Kidney Int. 2016 Nov;90(5):985-996
pubmed: 27457912
J Am Soc Nephrol. 2012 Oct;23(10):1631-4
pubmed: 22935483
Adv Chronic Kidney Dis. 2018 Sep;25(5):382-390
pubmed: 30309455
J Am Soc Nephrol. 2017 Sep;28(9):2670-2680
pubmed: 28600471
In Vivo. 2017 01-02;31(1):1-22
pubmed: 28064215
J Bone Miner Res. 2015 May;30(5):913-9
pubmed: 25400209
Kidney Int. 2003 Jul;64(1):350-5
pubmed: 12787428
Nat Rev Nephrol. 2012 Jun 19;8(8):484-90
pubmed: 22714041
Methods Mol Biol. 2012;816:279-303
pubmed: 22130936
Nephrol Dial Transplant. 2013 Jan;28(1):62-9
pubmed: 23045434
Physiol Rep. 2020 Jun;8(11):e14434
pubmed: 32476270
Kidney Int. 2007 Apr;71(8):738-43
pubmed: 17264878
Circ Res. 2021 May 28;128(11):1616-1625
pubmed: 33825489
PLoS One. 2016 Jul 06;11(7):e0158765
pubmed: 27383068
Circ J. 2017 Oct 25;81(11):1670-1677
pubmed: 28626160
Kidney Int. 1999 Jul;56(1):333-7
pubmed: 10411710
J Clin Invest. 2020 Mar 2;130(3):1513-1526
pubmed: 32065590
Curr Opin Nephrol Hypertens. 2013 Jul;22(4):397-404
pubmed: 23666415
BMC Nephrol. 2013 May 30;14:116
pubmed: 23718816
Front Endocrinol (Lausanne). 2018 Jun 11;9:311
pubmed: 29942284
Sci Rep. 2020 Jan 30;10(1):1524
pubmed: 32001792
BMC Nephrol. 2018 Dec 4;19(1):346
pubmed: 30509210
J Bone Miner Res. 2004 Mar;19(3):429-35
pubmed: 15040831
Am J Kidney Dis. 2019 Jul;74(1):120-131
pubmed: 30898362
Kidney Int. 2010 Dec;78(11):1136-53
pubmed: 20736988
Kidney Int. 2020 Apr;97(4):713-727
pubmed: 32059997
Nephrol Dial Transplant. 2006 Mar;21(3):591-7
pubmed: 16326737
J Am Soc Nephrol. 2011 Oct;22(10):1913-22
pubmed: 21903574
J Am Soc Nephrol. 2008 Nov;19(11):2193-203
pubmed: 18667733